Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 420.00
Bid: 410.00
Ask: 430.00
Change: 2.50 (0.60%)
Spread: 20.00 (4.878%)
Open: 417.50
High: 420.00
Low: 417.50
Prev. Close: 417.50
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tristel swings to half-year profit as revenue growth outpaces costs

Mon, 20th Feb 2023 09:37

(Alliance News) - Tristel PLC on Monday reported that it swung to an interim profit in the six months to December 31, as its disinfectant foam De Novo could be approved by the US Food & Drug Administration.

Tristel is a Cambridgeshire-based maker of infection prevention, contamination control and hygiene products.

The company said it swung to a half-year profit of GBP2.4 million, compared to a loss of GBP1.2 million a year prior. Revenue grew 15% to GBP17.5 million from GBP15.1 million, outpacing cost of sales, which widened 11% to GBP3.4 million from GBP3.0 million. Total administrative expenses narrowed 13% to GBP11.6 million from GBP13.3 million.

Tristel said basic earnings per share were 3.19 pence, swung from a loss of 2.08p per share.

The company declared an interim dividend of 2.62p per share, unchanged from a year ago.

Looking ahead, Tristel is optimistic, adding that if the US Food & Drug Administration approves De Novo, it will add a new dimension to its ambitions. De Novo is a disinfectant foam that can be used on ultrasound probes used for intra-cavitary and skin surface diagnostic procedures.

The company said it will deliver data regarding De Novo to the FDA by the March 2023 deadline.

Tristel shares were 7.9% higher at 340.00 pence each in London on Monday morning.

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
24 Apr 2014 15:41

Sector movers: Healthcare stocks rise as M&A fever continues

Global M&A activity gave stocks in the healthcare equipment and services a boost on Thursday, with Smith & Nephew rising strongly after a takeover bid for sector peer Biomet. US artificial joint maker Zimmer Holdings announced today that it would buy orthopaedic products group Biomet in a deal valu

Read more
13 Mar 2014 11:17

Tristel Welcomes Call To Tackle Drug-Resistant Organisms

LONDON (Alliance News) - Tristel PLC Thursday welcomed a call from Public Health England calling for NHS Trust chief executives to tackle multi-drug resistant organisms, often called ''superbugs." The circular from the UK Government Department of Health's executive agency, says that "carbap

Read more
3 Mar 2014 11:29

Tristel Hikes Interim Dividend As It Swings To Profit

LONDON (Alliance News) - Tristel PLC Monday raised its interim dividend as it swung into a pretax profit as revenue rose in the half-year ended December 31, 2013, and administrative expenses dropped. Tristel posted an interim dividend of 0.36 pence, up from 0.08 pence in the previous year.<

Read more
22 Jan 2014 13:43

UK MIDDAY BRIEFING: Jobless Rate Falls As UK Recovery Continues

LONDON (Alliance News) - The unemployment rate in the UK declined by more than expected in the three months to November 2013, leading to calls for renewed clarity around forward guidance from Bank of England Governor Mark Carney. Meanwhile, minutes from the BOE's latest Monetary Policy Committ

Read more
22 Jan 2014 10:56

UK WINNERS & LOSERS: Sage Group Leads Blue-Chip Gainers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Sage Group, up 4.9%. The business-management software company has reve

Read more
22 Jan 2014 08:36

Tristel Shares Jump As It Says Results To Beat Upgraded Expectations

LONDON (Alliance News) - Shares in Tristel rose 16% Wednesday morning after it said it expects to report revenue and pretax profit ahead of previously upgraded expectations for the six months ended December 31, 2013. The biotechnology company said it had seen a strong first half and expects

Read more
10 Dec 2013 11:00

Tristel raises profit expectations after strong first half trading

Hospital hygiene group Tristel has told shareholders that first-half profits will be higher than it expected after strong momentum continued in the UK and overseas. At its annual general meeting, the AIM-listed infection and contamination control provider said it expected to reverse the previous y

Read more
14 Oct 2013 15:40

STOCKS NEWS EUROPE-UK small caps underperform blue-chips

The FTSE Small Caps Index closes flat while junior-listed AIM shares rise 0.1 percent, underperforming a 0.6 percent rise on the mid-caps and a 0.3 percent gain on the blue chips. Tristel gains 7.3 percent after reporting a strong second half performance to round off the year, with revenu

Read more
14 Oct 2013 12:51

UPDATE: Tristel Widens Pretax Losses, Remains Cautiously Optimistic Following Restructuring

Read more
14 Oct 2013 08:32

Tristel Widens Pretax Losses, Remains Cautiously Optimistic Following Restructuring

Read more
14 Oct 2013 07:28

Second-half progress at Tristel

Cambridge-based contamination and infection control products maker Tristel reported full-year results ahead of expectations as a strong second half overshadowed a weak first-half performance. The group, whose Tristel Wipes System is a widely used disinfection method in ENT, Cardiology, IVF and Ult

Read more
18 Jan 2013 13:55

Tristel receives Chinese licence for wipes system

Tristel, a manufacturer of infection prevention, contamination control and hygiene products, has received a licence from the Health Department of the People's Republic of China to import and sell the Tristel Wipes System. The system decontaminates and disinfects non-lumened medical devices, such as

Read more
29 Oct 2012 07:30

Annual profit surge at Tristel

Cambridge based contamination and infection control products maker Tristel ramped up profit for the year ended June 30th 2012 and announced the resignation of Chairman Francisco Soler after 19 years at the helm. The group reported adjusted pre-tax profit of £0.75m for the period, up 48% from the sa

Read more
29 Aug 2012 16:08

Centamin director stocks up following increased gold production

Senior Independent Non-Executive Director at Centamin, Gordon Edward Haslam, purchased 52,056 shares in the Egypt-focused gold miner on Wednesday. Haslam purchased the shares at 76p each for a total of £39,563, taking his total holding to 102,056 shares. The transaction comes two weeks after the

Read more
23 Jul 2012 07:55

Tristel lifts full year forecast

Contamination and infection control products maker Tristel said it expects full year profit to come in ahead of previous forecasts after a strong performance across all of the group's divisions in late June. Results to 30 June 2012 will now show adjusted pre-tax profits in excess of £700,000. Last

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.